ABO血型与动脉瘤性蛛网膜下腔出血——一项先导研究
该回顾性单中心研究纳入2014年5月至2020年1月英国某神经外科收治的412例动脉瘤性蛛网膜下腔出血成人患者,按ABO血型和Rh状态分组,分析血型与基线特征及临床结局的关联。队列ABO血型分布与英国一般人群无显著差异;A型血患者发生迟发性脑缺血(DIND)的风险较非A型血患者显著增高(OR 1.88,95%CI 1.10-3.21)。
要点
- 412例aSAH成人患者中,ABO血型分布与英国一般人群无显著差异。
- A型血患者发生DIND的风险较非A型血患者显著增高(OR 1.88,95%CI 1.10-3.21)。
- 作者认为ABO血型似乎影响aSAH后遗症。
核心结论
- ABO血型似乎影响动脉瘤性蛛网膜下腔出血的后遗症,A型血患者发生迟发性脑缺血的风险最高。
研究设计与样本
- 回顾性单中心研究,纳入2014年5月至2020年1月英国某神经外科收治的412例动脉瘤性蛛网膜下腔出血成人患者,按ABO血型和Rh状态分组。
主要发现
- 队列ABO血型或Rh状态分布与英国一般人群无显著差异。
- A型血患者发生DIND的风险较非A型血患者显著增高(OR 1.88,95%CI 1.10-3.21)。
关键数值与推荐
- A型血患者较非A型血患者发生DIND的OR为1.88(95%CI 1.10-3.21)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the distribution and impact of ABO blood group on the baseline characteristics and clinical outcomes of patients presenting with aneurysmal subarachnoid haemorrhage (aSAH). METHODS: Retrospective, single-centre study of patients admitted to a neurosurgical department in the UK, with a diagnosis of spontaneous subarachnoid haemorrhage between May 2014 and January 2020. Patients were categorised by ABO blood type and by Rhesus status. Clinical outcomes such as initial bleeding, rebleeding, delayed cerebral ischaemia (DIND) and venous thromboembolism were analysed in relation to the size of their association with ABO blood type. Hospital mortality rate, Glasgow Outcome Score (GOS) - at discharge and 3 months post-ictus, requirement for ventriculoperitoneal shunt insertion, discharge destination and inpatient length of stay were also considered. RESULTS: Four-hundred twelve adult patients admitted with aSAH were included in our analysis. The distribution of ABO group or Rhesus status in our cohort did not differ significantly from the general population in the UK. Blood group A patients had a significantly increased risk of developing DIND, compared with non-blood group A patients (OR, 1.88 [95% CI: 1.10-3.21]). CONCLUSIONS: ABO blood type appears to influence aSAH sequelae. Blood group A patients are at highest risk of DIND following aSAH.
引用
- Richards O, Cromie KJ, Akhunbay-Fudge C, et al. ABO blood group in aneurysmal subarachnoid haemorrhage-a pilot study. Acta Neurochir (Wien). 2022. PMID: 35039955. doi:10.1007/s00701-021-05079-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。